These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of refractory epilepsy with dipropyl acetate]. Kugler J; Knörl G; Empt J Munch Med Wochenschr; 1973 Jun; 115(23):1103-8. PubMed ID: 4581303 [No Abstract] [Full Text] [Related]
4. [Clinical trial od Di-n-propylacetate in epileptics with therapy-resistant absences]. Lüdemann G; Cammann R-J ; Knaape H-H Psychiatr Neurol Med Psychol (Leipz); 1975 Feb; 27(2):101-7. PubMed ID: 812129 [TBL] [Abstract][Full Text] [Related]
5. [Modification of personality changes in epileptics using dipropylacetate (Convulex). Preliminary communication]. Deisenhammer E Wien Med Wochenschr; 1977 Jun; 127(12):370-3. PubMed ID: 333779 [No Abstract] [Full Text] [Related]
6. [Sodium di-n-propylacetate, effect in the treatment of resistant epilepsy. A controlled study]. Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jørgensen A; Sommerbeck KW; Løhren V Ugeskr Laeger; 1977 May; 139(18):1064-9. PubMed ID: 324058 [No Abstract] [Full Text] [Related]
7. [EEG and clinical study of Depakine in patients with comitial crises and-or mental disorders]. Salzarulo P; Lairy GC Riv Neurol; 1974 Mar; 44(2):77-94. PubMed ID: 4848745 [No Abstract] [Full Text] [Related]
8. [Experiences with dipropylacetate in the treatment of therapy-resistent adult epileptics]. Schäfer J; Kettner I Med Welt; 1974 Mar; 25(13):561-3. PubMed ID: 4827977 [No Abstract] [Full Text] [Related]
9. [Treatment of epilepsy in children using dipropyl acetic acid (DPA)]. Ritz A; Jacobi G Fortschr Med; 1973 May; 91(13):590-1 passim. PubMed ID: 4633749 [No Abstract] [Full Text] [Related]
10. [Sodium di-n-propylacetate: evaluation of its so-called psychotropic effect. A controlled study]. Sommerbeck KW; Theilgaard A; Rasmussen KE; Løhren V; Gram L; Wulff K Ugeskr Laeger; 1977 May; 139(18):1069-73. PubMed ID: 324059 [No Abstract] [Full Text] [Related]
11. [Clinical observations on the effect of dipropylacetic acid in epileptic and behavioral manifestations]. Mairlot F Rev Neuropsychiatr Infant; 1970 Mar; 18(3):269-78. PubMed ID: 5422825 [No Abstract] [Full Text] [Related]
12. [Neuro-psychiatric evaluation of Clonazepam (Ro 5-4023) in epileptic patients]. Caso A; Raphael-Fernández G; Romo A; Martínez C; Garibay E; Padilla J Gac Med Mex; 1973 Nov; 106(5):385-92. PubMed ID: 4769733 [No Abstract] [Full Text] [Related]
13. [Trial of a new antiepileptic drug, magnesium dipropyl acetate]. de Pasquet EG; Gomensoro JB; de Bustos LF; Tenzer SM Acta Neurol Latinoam; 1973; 19(1-4):119-28. PubMed ID: 4619958 [No Abstract] [Full Text] [Related]
14. [On the use of DPA in hospitalized epileptics]. Motta E; De Natale F Riv Neurol; 1973; 43(4):287-94. PubMed ID: 4782473 [No Abstract] [Full Text] [Related]
15. [Study of the effects of Tegretol on a population of epileptic children]. Martin F; Movarrekhi M; Gisiger MG Schweiz Med Wochenschr; 1965 Jul; 95(29):982-9. PubMed ID: 5319730 [No Abstract] [Full Text] [Related]
16. [Sodium salt of n-dipropylacetic acid or Depakin in the therapy of epilepsy. Preliminary note]. Campanella G; Cantini A; Damiani A Riv Neurol; 1972; 42(5):452-8. PubMed ID: 4631199 [No Abstract] [Full Text] [Related]
17. Clonazepam--a clinical study of its effectiveness as an anticonvulsant. Edwards VE; Eadie MJ Proc Aust Assoc Neurol; 1973; 10(0):61-6. PubMed ID: 4600355 [No Abstract] [Full Text] [Related]
18. Letter: Preliminary experience with sodium valproate. Ronthal M S Afr Med J; 1975 Jun; 49(27):1077. PubMed ID: 1098174 [No Abstract] [Full Text] [Related]